Mosaic ImmunoEngineering Inc. (CPMV): Operating Income

Annual figures by period end, from SEC filings.

-$616.1K

Year ended 2025-12-31

-$604.0K

Trailing 12 months to 2026-06-30

2021-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$616.1K	n/m	2026-04-15, From 2025-01-01
2024-12-31	-$879.7K	n/m	2026-04-15, From 2024-01-01
2023-12-31	-$1.40M	n/m	2025-04-15, From 2023-01-01
2022-12-31	-$2.63M	n/m	2024-04-15, From 2022-01-01
2021-12-31	-$3.50M	n/a	2023-03-02, From 2021-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Mosaic ImmunoEngineering Inc. (CPMV)	2025-12-31	-$616.1K	n/m
Agentix Corp. (AGTX)	2026-03-31	-$445.2K	n/m
Liminatus Pharma, Inc. (LIMN)	2025-12-31	-$2.97M	n/m
Adaptin Bio, Inc. (APTN)	2025-12-31	-$5.41M	n/m
Brainstorm Cell Therapeutics Inc. (BCLI)	2025-12-31	-$9.95M	n/m
Abpro Holdings, Inc. (ABPO)	2025-12-31	-$8.45M	n/m
Zeo ScientifiX, Inc. (ZEOX)	2025-10-31	-$5.39M	n/m
Zivo Bioscience, Inc. (ZIVO)	2024-12-31	-$13.36M	n/m
Estrella Immunopharma, Inc. (ESLA)	2025-12-31	-$13.06M	n/a

Compare CPMV, AGTX, LIMN, APTN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗